From a patient safety perspective, individuals should seek prompt medical advice if they experience: Severe or persistent abdominal pain (which may indicate pancreatitis) Right-upper-quadrant pain, fever, or jaundice (which may indicate a gallbladder problem) Rapid or irregular heartbeat Symptoms of hypoglycaemia, such as shakiness, sweating, or confusion Signs of an allergic reaction, such as rash, swelling, or difficulty breathing If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
doi: 10.1155/2016/8160393
For tirzepatide, the company lists sublingual drops starting at approximately $224.10 per month and injectable tirzepatide at approximately $399.00 per month
Ahmadi F, Etemadi SM, Lessan-Pezeshki M, Mahdavi-Mazdeh M, Ayati M, Mir A, Yazdi HR